Clinical Trials Browser

Unknown × INDUSTRY × CNS × Clear all

NCT01107522 2025-09-09

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Phase 1 Unknown

Glioblastoma, Glioma

NCT06353360 2024-08-09

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

Phase 2 Unknown

Glioblastoma

NCT06363201 2024-04-12

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

Phase NA Unknown

CNSLymphoidSarcoma

Hodgkin Disease, Neoplasms, Neoplasms, Germ Cell and Embryonal, Sarcoma, Central Nervous System Neoplasms

NCT04573192 2024-04-08

GLIOSTAR

Phase 1/2 Unknown

Glioblastoma

NCT05868083 2024-02-23

The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT05549414 2023-07-10

PPTS

Phase NA Unknown

Brain Neoplasms, Head and Neck Neoplasms

NCT05191784 2023-06-12

GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

Phase 2 Unknown

Glioblastoma

NCT05728125 2023-06-12

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Glioblastoma

NCT03613181 2023-04-24

ANGLeD

Phase 3 Unknown

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT01672463 2023-03-29

OKN-007

Phase 1 Unknown

Glioma

NCT03561207 2023-03-24

3D-PREDICT

Astrocytoma, Glioblastoma, Ovarian Neoplasms

NCT05782959 2023-03-24

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Phase 1 Unknown

Neuroblastoma

NCT05739500 2023-02-22

MRI-based Computer Aided Diagnosis Software (V1) for Glioma

Brain Neoplasms, Glioma

NCT03561259 2023-02-16

OPTIMUM

Phase 2 Unknown

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

NCT03793088 2023-02-03

XCELSIOR

10,000 enrolled

Glioblastoma, Glioma, Neoplasms

NCT04642937 2023-01-27

Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT04717739 2023-01-10

TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study

Glioblastoma

NCT05540873 2023-01-06

A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)

Phase 1 Unknown

Glioma

NCT03750071 2022-10-20

VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma

Phase 1/2 Unknown

Glioblastoma

NCT05095441 2022-10-12

A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT05573815 2022-10-10

Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images

Phase NA Unknown

Brain Neoplasms

NCT03722342 2022-08-17

TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT05447195 2022-07-12

Phase 2 Study of CAN008 in Subjects With GBM

Phase 2 Unknown

Glioblastoma

NCT00045968 2022-05-18

GBM

Phase 3 Unknown

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT05092802 2022-05-03

The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment

Phase 2 Unknown

Brain Neoplasms

NCT05333588 2022-04-19

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

Phase EARLY_PHASE1 Unknown

Glioblastoma, Glioma

NCT05051488 2022-04-06

Dynamic Decompressive Craniotomy

Brain Injuries, Traumatic, Brain Edema, Brain Neoplasms, Cerebral Hemorrhage, Intracranial Hypertension, Stroke

NCT02796261 2022-01-21

STELLAR

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioma

NCT03400917 2021-12-16

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Phase 2 Unknown

Newly Diagnosed Glioblastoma

NCT05053880 2021-11-19

A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

Phase 1/2 Unknown

Glioblastoma, Neoplasms

NCT05107037 2021-11-04

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis

Phase 1 Unknown

Neurofibromatoses

NCT05063682 2021-10-01

CARTREMENDOUS

Phase 1 Unknown

Glioblastoma, Glioma

NCT04906473 2021-05-28

Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Glioma

NCT03008148 2021-05-11

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Phase 2/3 Unknown

Glioblastoma

NCT04864821 2021-05-06

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

Phase EARLY_PHASE1 Unknown

CNSGastrointestinalSarcomaThoracic

Lung Neoplasms, Neuroblastoma, Osteosarcoma, Stomach Neoplasms

NCT04874506 2021-05-05

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Phase 2 Unknown

Glioblastoma

NCT03941626 2021-02-04

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

Phase 1/2 Unknown

CNSGastrointestinal

Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Stomach Neoplasms

NCT03258021 2021-01-28

TIGER

Glioblastoma

NCT04717999 2021-01-22

Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma

Phase NA Unknown

Glioblastoma

NCT03896958 2020-12-04

PIONEER

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma of Lung, Adrenal Gland Neoplasms, Anus Neoplasms, Bile Duct Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, Neurologic Manifestations, Oligodendroglioma, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

NCT03734913 2020-07-22

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

Phase 1 Unknown

CNSDermatologicEndocrineNETThoracic

Carcinoma, Basal Cell, Glioblastoma, Medulloblastoma, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT04450160 2020-06-29

AEO

Phase 2 Unknown

Glioblastoma, Seizures

NCT03231501 2020-06-16

HMPL-813 in Treating Patients With Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT04415320 2020-06-04

X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04277221 2020-03-17

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Phase 3 Unknown

Glioblastoma

NCT00874614 2020-02-20

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Phase 2 Unknown

74 enrolled 10 charts 1 FDA

CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT04178057 2019-11-27

Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.

Phase 1 Unknown

Brain Neoplasms

NCT02775136 2019-10-30

An Evaluation of a Non-invasive Brain Monitor

Phase NA Unknown

Brain Injuries, Brain Neoplasms, Hydrocephalus, Subarachnoid Hemorrhage, Vasospasm, Intracranial

NCT04058704 2019-08-15

SMART

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung